Lupus erythematosus
Lupus erythematosus
Lupus is a disease
that occurs when your body's immune system attacks your tissues and organs
(autoimmune disease). Inflammation caused by lupus can affect many different
body systems—including your joints, skin, kidneys, blood cells, brain, heart,
and lungs.
Lupus can be challenging to diagnose because its signs and symptoms often resemble those of other conditions. The most distinctive sign of
lupus—a facial rash that resembles the wings of a butterfly unfolding across
both cheeks—occurs in many but not all cases of lupus.
Lupus erythematosus is
a collection of autoimmune diseases in which the human immune system becomes hyperactive and attacks healthy tissues. Symptoms of these diseases can affect multiple body systems, including the joints, skin, kidneys, blood cells, heart, and lungs.
The signs
and symptoms of lupus that you experience will depend on which body systems are
affected by the disease. The most common signs and symptoms include: Fatigue, Fever,
Joint pain, stiffness, and swelling, Butterfly-shaped rash on the face that
covers the cheeks and bridge of the nose or rashes elsewhere on the body, Skin
lesions that appear or worsen with sun exposure, Fingers and toes that turn
white or blue when exposed to cold or during stressful periods, Shortness of
breath, Chest pain. Dry eyes, Headaches, confusion, and memory loss
Symptoms vary from person to person and may come and go. Almost everyone
with lupus has joint pain and swelling. Some develop arthritis. Other common symptoms include chest pain during respiration, joint pain, painless oral ulcers, fatigue, weight loss, and headaches. Skin lesions that appear worse after sun exposure, general
discomfort, uneasiness, or ill feeling (malaise), hair loss
It is typically believed
that lupus is influenced by multiple genes.
Lupus can develop in
people at any age, but it does most commonly develop at ages 15 to 44, with
varying results. Typically, the manifestation of the disease tends to be more
acute in those of younger age. Women are more likely to get it than men.
Patients with juvenile-onset lupus are more vulnerable to mucocutaneous
manifestations of the disease (alopecia, skin rash, and ulceration of the
mucous membranes). Patients with late-onset lupus have a much higher mortality
rate. Nearly 50% of those with late-onset lupus die of their condition. Women
who are of childbearing age are also particularly at risk.
Diagnosis of lupus will
vary from person to person. For lupus, a lot of the symptoms may manifest
as systemic disease. Lupus has many types. Of these, systemic lupus erythematosus (also known as SLE) is the most common and serious form.
Treatment—There is still no cure for
lupus, but there are options to help control symptoms. Treatment consists
primarily of immunosuppressive drugs. The goal for treatment is to prevent flare-ups
and reduce organ damage. Treatment for lupus depends on your signs and
symptoms. Determining whether you should be treated and what medications to use
requires a careful discussion of the benefits and risks with your doctor.
As your signs and symptoms flare and subside, you and your doctor may find
that you'll need to change medications or dosages. Doctors may prescribe a handful of different medications to help with their
patients' symptoms.
1.
Nonsteroidal anti-inflammatory
drugs (NSAIDs).
2.
Corticosteroids
3.
Antimalarial drugs
4.
BLyS-specific inhibitors
5.
Immunosuppressive agents/chemotherapy. In addition to medical therapy, cognitive behavioural therapy has
also been demonstrated to be effective in reducing stress, anxiety, and
depression due to the psychological and social impacts that lupus may have. - Immunosuppressants. Drugs
that suppress the immune system may be helpful in serious cases of lupus.
Examples include azathioprine (Imuran, Azasan), mycophenolate (Cellcept), methotrexate (Trexall, Xatmep, others),
cyclosporine (Sandimmune, Neoral, Gengraf), and leflunomide (Arava).
Potential side effects may include an increased risk of infection, liver
damage, decreased fertility, and an increased risk of cancer.
6.
People with SLE treated with standard care
experience a higher risk of opportunistic infections and death than the general
population. In clinical trials, voclosporin has been shown to be effective in treating
lupus.
Other
potential drugs to treat lupus are currently being studied, including abatacept
(Orencia), anifrolumab, and others.
Comments
Post a Comment